Here are some metrics and results from the various Keane VC Consult universe. We are consolidating all activities into one post in hopes it adds simplicity to the user experience and improve life. We hope this site can be used a networking tool for all involved. There are likely tools that one entity has that would help the other entities. Hope all are healthy and safe!
RevGen Trading
Date Entry | Security | Type | Cost | Date Sold | Amount Received
| Per Contract / Share Result |
9/8/20 | XLF | Sep 11 $23.50 Put | $0.13 | 9/11 | $0.00 | -$0.13 |
Notes
- The XLF trade was a speculative trade that did not follow through.
KDK Fund
Security/ Project | Type | Date of Purchase/Sale | Cost of Investment | EOW Value | Return % |
Fuel Cell Energy | Stock | 8/3/2020 | $2.10 | 2.17 | 3.33% |
Fuel Cell Energy | Sep 18 $3.00 Covered Call | 9/10/2020 | -$0.05 | -0.02 | 60.00% |
Silvergate Bank | Stock | 8/5/2020 | $13.99 | $14.98 | 7.08% |
Kintara Therapeutics | Stock | 8/21 | $1.21 | $1.60 | 32.23% |
Notes
- The FCEL Sept $4 call was bought back for $0.02 (setting a profit on the trade of $0.14 per contract) and the Sept $3 call was sold for $0.05.
- FCEL released earnings, with data from the company here. Important notes include a loss of $0.07 for the quarter and a cash balance of $66 million.
- Kintara Therapeutics hit a new 52 week high on Friday.
Charity
- Funds are accumulating. A distribution is likely after the September call option expires and KDK Fund makes an October covered call trade.
** This blog is used for opinions and ideas and should not be used as a direction to act without doing your due diligence. As always, we are on Facebook, Twitter, and email through keanevcc@gmail.com**